Factors that are associated with bleeding in LVAD patients
| Factors . |
|---|
| Use of anticoagulant drugs |
| Unfractionated heparin, low-molecular weight heparin, vitamin K antagonists |
| Antiplatelet drugs |
| Aspirin, clopidogrel |
| Platelet dysfunction |
| Thrombocytopenia |
| Acquired von Willebrand syndrome |
| Arteriovenous malformations/angiodysplasia |
| Impaired renal function |
| Infectious complications (disseminated intravascular coagulation) |
| ECMO support pre-LVAD implantation |
| Factors . |
|---|
| Use of anticoagulant drugs |
| Unfractionated heparin, low-molecular weight heparin, vitamin K antagonists |
| Antiplatelet drugs |
| Aspirin, clopidogrel |
| Platelet dysfunction |
| Thrombocytopenia |
| Acquired von Willebrand syndrome |
| Arteriovenous malformations/angiodysplasia |
| Impaired renal function |
| Infectious complications (disseminated intravascular coagulation) |
| ECMO support pre-LVAD implantation |